Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A

Antonino Cannavò, Carla Valsecchi, Isabella Garagiola, Roberta Palla, Pier Mannuccio Mannucci, Frits R. Rosendaal, Flora Peyvandi

Blood (2017) 129 (10): 1245–1250.

https://doi.org/10.1182/blood-2016-06-720086

Published: 2017

Includes: Supplemental data

Journal Articles

Natural History of Patients Affected with Thrombotic Thrombocytopenic Purpura: Milan TTP Registry

Ilaria Mancini, PhD, Silvia Pontiggia, BSc, Barbara Ferrari, MD, Andrea Artoni, MD PhD, Antonino Cannavò, MD, Silvia Maria Trisolini, MD, Luca Facchini, MD, Erminia Rinaldi, MD, Flora Peyvandi, MD PhD

Blood (2016) 128 (22): 3731.

https://doi.org/10.1182/blood.V128.22.3731.3731

Published: 2016

Journal Articles

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Flora Peyvandi, MD PhD, Antonino Cannavò, MD, Isabella Garagiola, PhD, Roberta Palla, PhD, Frits Rosendaal, MD PhD, Piermannuccio Mannucci, MD

Blood (2016) 128 (22): 330.

https://doi.org/10.1182/blood.V128.22.330.330

Published: 2016

Journal Articles

Clots from FXI-Deficient Patients Display a Reduced Fibrinolytic Resistance

Flora Peyvandi, Antonino Cannavò, Francesca Incampo, Marzia Menegatti, Nicola Semeraro, Eugenia Biguzzi, Simona Maria Siboni, Mario Colucci

Blood (2014) 124 (21): 4219.

https://doi.org/10.1182/blood.V124.21.4219.4219

Published: 2014

Journal Articles

Patients with Mild Hemophilia a with Discrepant FVIII Assays: Thrombin Generation and Bleeding Phenotype

Maria Elisa Mancuso, MD PhD, Maria Rosaria Fasulo, MD, Antonino Cannavò, MD, Flora Peyvandi, MD PhD, Elena Santagostino, MD PhD

Blood (2014) 124 (21): 2844.

https://doi.org/10.1182/blood.V124.21.2844.2844

Published: 2014

Journal Articles

Is Hemophilia B Less Severe Than Hemophilia A? Results Of Global Coagulation Assays

Maria Rosaria Fasulo, MD, Maria Elisa Mancuso, MD, PhD, Veena Chantarangkul, Antonino Cannavò, MD, Marigrazia Clerici, Lidia Padovan, Erica Scalambrino, Flora Peyvandi, Armando Tripodi, MD, Elena Santagostino, MD, PhD

Blood (2013) 122 (21): 2352.

https://doi.org/10.1182/blood.V122.21.2352.2352

Published: 2013

NARROW

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A

Natural History of Patients Affected with Thrombotic Thrombocytopenic Purpura: Milan TTP Registry

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Clots from FXI-Deficient Patients Display a Reduced Fibrinolytic Resistance

Patients with Mild Hemophilia a with Discrepant FVIII Assays: Thrombin Generation and Bleeding Phenotype

Is Hemophilia B Less Severe Than Hemophilia A? Results Of Global Coagulation Assays

Email alerts

ASH Publications

American Society of Hematology

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A

Natural History of Patients Affected with Thrombotic Thrombocytopenic Purpura: Milan TTP Registry

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Clots from FXI-Deficient Patients Display a Reduced Fibrinolytic Resistance

Patients with Mild Hemophilia a with Discrepant FVIII Assays: Thrombin Generation and Bleeding Phenotype

Is Hemophilia B Less Severe Than Hemophilia A? Results Of Global Coagulation Assays

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only